Literature DB >> 8574829

Comparison of the vibriocidal antibody response in cholera due to Vibrio cholerae O139 Bengal with the response in cholera due to Vibrio cholerae O1.

F Qadri1, G Mohi, J Hossain, T Azim, A M Khan, M A Salam, R B Sack, M J Albert, A M Svennerholm.   

Abstract

Vibrio cholerae serogroup O139, now considered to be the second organism capable of causing epidemic severe dehydrating cholera, contains a capsular polysaccharide which makes it difficult for it to be used in the conventional vibriocidal antibody assay optimized for V. cholerae O1. After modification of the procedure, which involved the use of specific bacterial strains, a lower bacterial inoculum, and increased amounts of complement, the vibriocidal antibody responses to V. cholerae O139 were measured in acute- and convalescent-phase sera from 33 V. cholerae O139-infected and 18 V. cholerae O1-infected patients and in single serum samples from 20 healthy control subjects. The responses in these individuals to V. cholerae O1 strains were also determined. Significant elevations in the homologous antibody response were found only in the convalescent-phase sera from both groups of patients with cholera. These findings may explain the basis for the lack of heterologous protection between the two serogroups of V. cholerae. Healthy controls had higher background levels of vibriocidal antibody to V. cholerae O1 than to V. cholerae O139.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8574829      PMCID: PMC170220          DOI: 10.1128/cdli.2.6.685-688.1995

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  18 in total

Review 1.  Vibrio cholerae O139 Bengal.

Authors:  M J Albert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

2.  Lack of cross-protection against diarrhea due to Vibrio cholerae O139 (Bengal strain) after oral immunization of rabbits with V. cholerae O1 vaccine strain CVD103-HgR.

Authors:  M J Albert; K Alam; M Ansaruzzaman; F Qadri; R B Sack
Journal:  J Infect Dis       Date:  1994-01       Impact factor: 5.226

3.  Lack of cross-protection against diarrhea due to Vibrio cholerae O1 after oral immunization of rabbits with V. cholerae O139 Bengal.

Authors:  M J Albert; K Alam; A S Rahman; S Huda; R B Sack
Journal:  J Infect Dis       Date:  1994-03       Impact factor: 5.226

4.  Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.

Authors:  A M Svennerholm; M Jertborn; L Gothefors; A M Karim; D A Sack; J Holmgren
Journal:  J Infect Dis       Date:  1984-06       Impact factor: 5.226

5.  Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers.

Authors:  J G Morris; G E Losonsky; J A Johnson; C O Tacket; J P Nataro; P Panigrahi; M M Levin
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

6.  Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.

Authors:  A Weintraub; G Widmalm; P E Jansson; M Jansson; K Hultenby; M J Albert
Journal:  Microb Pathog       Date:  1994-03       Impact factor: 3.738

7.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

8.  Vibrio cholerae non-O1 serogroup associated with cholera gravis genetically and physiologically resembles O1 E1 Tor cholera strains.

Authors:  R H Hall; F M Khambaty; M H Kothary; S P Keasler; B D Tall
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

9.  Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal.

Authors:  F Qadri; T Azim; A Chowdhury; J Hossain; R B Sack; M J Albert
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

10.  The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.

Authors:  L E Comstock; D Maneval; P Panigrahi; A Joseph; M M Levine; J B Kaper; J G Morris; J A Johnson
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

View more
  50 in total

1.  Sensitive microplate assay for detection of bactericidal antibodies to Vibrio cholerae O139.

Authors:  Stephen R Attridge; Camilla Johansson; Dang D Trach; Firdausi Qadri; Ann-Mari Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.

Authors:  F Qadri; G Jonson; Y A Begum; C Wennerås; M J Albert; M A Salam; A M Svennerholm
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

3.  Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh.

Authors:  Daniel T Leung; Mohammad Arif Rahman; M Mohasin; Sweta M Patel; Amena Aktar; Farhana Khanam; Taher Uddin; M Asrafuzzaman Riyadh; Amit Saha; Mohammad Murshid Alam; Fahima Chowdhury; Ashraful Islam Khan; Richelle Charles; Regina LaRocque; Jason B Harris; Stephen B Calderwood; Firdausi Qadri; Edward T Ryan
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

4.  Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera.

Authors:  Mohammad Murshid Alam; M Asrafuzzaman Riyadh; Kaniz Fatema; Mohammad Arif Rahman; Nayeema Akhtar; Tanvir Ahmed; Mohiul Islam Chowdhury; Fahima Chowdhury; Stephen B Calderwood; Jason B Harris; Edward T Ryan; Firdausi Qadri
Journal:  Clin Vaccine Immunol       Date:  2011-02-23

5.  Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.

Authors:  Anne L Bishop; Stefan Schild; Bharathi Patimalla; Brian Klein; Andrew Camilli
Journal:  Infect Immun       Date:  2010-08-02       Impact factor: 3.441

6.  Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.

Authors:  E Paulovicová; E Machová; A Hostacká; S Bystrický
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

7.  Cholera caused by Vibrio cholerae O1 induces T-cell responses in the circulation.

Authors:  Taufiqur Rahman Bhuiyan; Samuel B Lundin; Ashraful Islam Khan; Anna Lundgren; Jason B Harris; Stephen B Calderwood; Firdausi Qadri
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

8.  Acute dehydrating disease caused by Vibrio cholerae serogroups O1 and O139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut.

Authors:  F Qadri; T R Bhuiyan; K K Dutta; R Raqib; M S Alam; N H Alam; A-M Svennerholm; M M Mathan
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

9.  Cholera in pregnancy: Clinical and immunological aspects.

Authors:  Ashraful I Khan; Fahima Chowdhury; Daniel T Leung; Regina C Larocque; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Firdausi Qadri
Journal:  Int J Infect Dis       Date:  2015-08-14       Impact factor: 3.623

10.  Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh.

Authors:  Jason B Harris; Michael J Podolsky; Taufiqur R Bhuiyan; Fahima Chowdhury; Ashraful I Khan; Regina C Larocque; Tanya Logvinenko; Jennifer Kendall; Abu S G Faruque; Cathryn R Nagler; Edward T Ryan; Firdausi Qadri; Stephen B Calderwood
Journal:  PLoS Negl Trop Dis       Date:  2009-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.